MTNB
Matinas BioPharma Holdings Inc
NYSE MKT: MTNB · HEALTHCARE · BIOTECHNOLOGY
$0.61
+2.87% today
Updated 2026-04-29
Market cap
$3.91M
P/E ratio
—
P/S ratio
34.81x
EPS (TTM)
$-2.00
Dividend yield
—
52W range
$0 – $3
Volume
0.0M
Matinas BioPharma Holdings Inc (MTNB) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-57264.00 | $-2.99M | $-7.96M | $-7.81M | $-6.12M | $-11.46M | $-10.32M | $-14.09M | $-17.37M | $-15.22M | $-19.16M | $-15.28M | $-15.88M | $-7.01M |
| Capital expenditures | $0.00 | $94188.00 | $288519.00 | $76179.00 | $942180.00 | $942180.00 | $535916.00 | $405604.00 | $5749.00 | $260380.00 | $892000.00 | $218000.00 | $0.00 | $0.00 |
| Depreciation | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Stock-based comp | — | $325740.00 | $1.97M | $1.59M | $1.52M | $3.60M | $3.83M | $2.99M | $4.56M | $4.29M | $5.23M | $4.95M | $3.19M | $1.02M |
| Free cash flow | $-57264.00 | $-3.08M | $-8.25M | $-7.89M | $-7.06M | $-12.40M | $-10.86M | $-14.50M | $-17.37M | $-15.48M | $-20.05M | $-15.50M | $-15.88M | $-7.01M |
| Investing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Dividends paid | — | — | — | — | $4.39B | $608.34M | $587.14M | $2.23B | $682.80M | $843.60M | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | $-8.25M | $636284.00 | — | — | $5.01M | $9.75M | $-9.99M | $8.51M | $-14.20M | — | — | — |